Most of the cases are asymptomatic or with mild symptoms (Headache, fever, and myalgia).

Newborns and children up to the age of 15 years are more vulnerable to JE with the increased threat of neurological complications over adult.

High mortality rate, who survives, 20-30% suffer permanent neurologic sequels.

JEV distribution on Asia. Data reported from 2023 at Centers for disease control and prevention. CDC, cdc.gov/japaneseencephalitis/maps/index.html

According with WHO, in 2019 were reporter almost 68,000 cases of JE with 20-30 % mortality rate.

2 millions people living in endemic countries with JEV, Sporadic outbreaks in the Western Pacific and northern Australia are also observed. Recently outbreak was observed in southern Australia 2022.

The major causes of viral encephalitis in Asia.

There are approved vaccine use as pre-travel precaution in endemic countries, where multiple doses of vaccine are recommended. Although large-scale vaccination of susceptible population must be implemented.

There is any antivirals available at the moment for the prevention or treatment of JE infection.